A Study of Lerociclib in Participants With Advanced Breast Cancer
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: DRUG: Lerociclib + Letrozole or Fulvestrant
Sponsor: EQRx, Inc.